Innovations in viral vector development, scale up and production

Available On Demand

Sign Up:

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.



Viral vectors have taken a striking importance in the current biomanufacturing landscape, with the unprecedented global need for viral particles creating significant capacity and productivity challenges. Join our educational webinar and learn how recent innovation can help you to significantly push the boundaries of viral vectors productivity and quality.

Discover how recent innovation in areas such as cells, media and transfection agents can boost and standardise your process, as illustrated by our lentiviral case study. Get updates about recent innovations in both benchtop and production scale bioreactors, significantly impacting data transfer and manufacturing footprint alike.

Lastly, in the challenging context of purifying active vectors whilst removing high amounts of contaminants, find out about disruptive affinity approaches and purpose-designed analytics to support next-generation downstream process development.

Key topics:

  • Scalable plasmid manufacturing in single-use format
  • LV Max technology for lentiviral production
  • Next generation benchtop controllers: the power of a Distributed Control System for R&D
  • Next generation single-use bioreactors
  • Viral vectors scalable affinity purification
  • Residual DNA testing for HEK host cells


  • Guest Speaker - Thomas Guarinoni, DSP Manager (Viralgen VC)
  • Céline Martin, Cell and Gene Therapy, Business Development
  • Ian Pringle, Cell Culture, R&D
  • Floris Hooijenga, Bioprocessing Equipment and Automation, Technical Sales Specialist
  • Zoltan Gulyas, Purification, Field Application Specialist
  • Rob Osborne, Pharmaceutical Analytics, Technical Sales Specialist
  • Jason Brown, Design Egineer, Single-use Technologies


    For Research Use or Further Manufacturing Only. Not for diagnostic use or direct administration into humans or animals.


Céline Martin
Cell and Gene Therapy
Business Development
Ian Pringle
Cell Culture
Floris Hooijenga
Bioprocessing Equipment and Automation
Technical Sales Specialist
Zoltan Gulyas
Field Application Specialist
Rob Osborne
Pharmaceutical Analytics
Technical Sales Specialist
Jason Brown
Design Egineer
Single-use Technologies